Eli Lilly
LLY
LLY
1,880 hedge funds and large institutions have $134B invested in Eli Lilly in 2020 Q4 according to their latest regulatory filings, with 242 funds opening new positions, 658 increasing their positions, 675 reducing their positions, and 104 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
8% more call options, than puts
Call options by funds: $870M | Put options by funds: $807M
3% less repeat investments, than reductions
Existing positions increased: 658 | Existing positions reduced: 675
2% less funds holding in top 10
Funds holding in top 10: 49 → 48 (-1)
Holders
1,880
Holding in Top 10
48
Calls
$870M
Puts
$807M
Top Buyers
| 1 | +$8.44B | |
| 2 | +$1.32B | |
| 3 | +$689M | |
| 4 |
KBC Group
Brussels,
Belgium
|
+$587M |
| 5 |
JP Morgan Chase
New York
|
+$452M |
Top Sellers
| 1 | -$805M | |
| 2 | -$714M | |
| 3 | -$456M | |
| 4 |
Two Sigma Advisers
New York
|
-$320M |
| 5 |
BlackRock
New York
|
-$280M |